An alternative method to the evaluation of similarity factor in dissolution testing.
about
Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.Characterisation of zinc delivery from a nipple shield delivery system using a breastfeeding simulation apparatusUse of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.Bioequivalence of 2 azithromycin capsule formulations: a randomized, single-dose, open-label, 2-period crossover study in healthy male pakistani volunteers.Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies.Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.New sustained release of zidovudine matrix tablets - cytotoxicity toward Caco-2 cells.Transfer of drug dissolution testing by statistical approaches: Case studyIn vitro dissolution and in vivo bioavailability of six brands of ciprofloxacin tablets administered in rabbits and their pharmacokinetic modeling.Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis.Evaluation of ionotropic cross-linked chitosan/gelatin B microspheres of tramadol hydrochloride.Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gumA new drug release method in early development of transdermal drug delivery systems.Formulation and evaluation of sustained release bioadhesive tablets of ofloxacin using 3(2) factorial design.Design of a novel bilayered gastric mucoadhesive system for localized and unidirectional release of lamotrigine.Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile.The impact of manufacturing variables on in vitro release of clobetasol 17-propionate from pilot scale cream formulations.Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.Thermodynamic Changes Induced by Intermolecular Interaction Between Ibuprofen and Chitosan: Effect on Crystal Habit, Solubility and In Vitro Release Kinetics of Ibuprofen.Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs.Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.Comparative in vitro-in vivo correlation analysis with pioglitazone tablets
P2860
Q35558002-14DC4CE4-42FB-453E-9254-60E8867C377DQ36269992-E1E2DD75-F3D6-4807-A211-17016875FEEDQ37361053-BB11D745-D306-4DEB-A8DC-3E35D8CA7D8BQ38310505-1F463DA7-3323-4FCD-83CE-CC931617FE3FQ38762614-46E42BC5-9940-440B-A580-A3B4305D1864Q38787316-3E4DB376-CC03-447C-B299-AB0DA1288EDDQ39014487-613E7DF5-EF95-4812-AFDA-D0A75304DB0FQ39375439-67E07E3E-C4BB-45A6-AB33-FAA5C44A8647Q39670222-39D9EBF4-9306-4D7D-93C8-6F7BB583B3D2Q40960278-519382AE-565A-4469-B964-D85A268ADCC0Q41321186-25F5498C-46A0-4A21-9EF8-E853841FEC75Q41870433-380F6163-32A5-450F-936A-0ED7C099AD19Q41989226-B9A88E0F-E5EB-47A8-98EA-055D60DCCFC1Q42241071-C908486F-D814-4B77-903A-5929C806006BQ42497446-DEEF67CD-D6C8-4C32-A1EF-2960905C9FE6Q42651311-2589C69A-0FB8-4881-8862-0DA568EB8AF9Q43250327-389DB847-18C0-4691-8932-75A8279A9AFAQ43549760-F0C2E302-05C3-4AFF-845D-E36356091762Q45741798-DEBFBF90-79E0-4D1D-8E56-45E9896AA3AEQ45947550-DC922F52-BA61-4321-BF7C-FAAE8C8433B7Q46915945-3DB74D1D-A24C-4DEA-92F3-CF1BD97397D8Q50442842-D952AE9E-64D2-4D38-B91F-2E5031F7D162Q51701301-F9C64C49-A0C0-4F20-BB01-01043BD0889DQ57932324-EB7F6FD3-05B3-40E5-B284-8A7695D49923
P2860
An alternative method to the evaluation of similarity factor in dissolution testing.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
An alternative method to the evaluation of similarity factor in dissolution testing.
@en
An alternative method to the evaluation of similarity factor in dissolution testing.
@nl
type
label
An alternative method to the evaluation of similarity factor in dissolution testing.
@en
An alternative method to the evaluation of similarity factor in dissolution testing.
@nl
prefLabel
An alternative method to the evaluation of similarity factor in dissolution testing.
@en
An alternative method to the evaluation of similarity factor in dissolution testing.
@nl
P1476
An alternative method to the evaluation of similarity factor in dissolution testing.
@en
P2093
P356
10.1016/S0378-5173(01)00651-2
P407
P577
2001-06-01T00:00:00Z